Comparing implementation strategies for optimizing depression care: A randomized control trial

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Importance

Less than a third of depressed primary care patients experience clinical improvement, in part due to a lack of focus on treatment optimization (e.g., intensification).

Objective

To compare the impact of implementation and behavioral science informed system and multi-level strategies on population-wide treatment optimization in integrated/collaborative care model (CoCM) settings.

Design

Comparative effectiveness randomized controlled trial

Setting

5 Primary care clinics with a mature integrated/CoCM

Participants

44 primary care physicians and their patients with elevated depressive symptoms eligible for treatment optimization

Exposures

System-level strategy (i.e., enhanced usual care [EUC]) focused on staff and behavioral health provider (BHP) activation vs. multi-level strategy (intervention) involving BHP activation, primary care provider (PCP) behavioral support and a patient activation/psychoeducation tool (DepCare)

Main outcomes and measures

Patient optimization (e.g., filling a new, intensified/augmented, or previously nonadherent antidepressant and/or completing a new integrated/CoCM visit) during the 4 months following an index visit and PCP optimization (e.g., placing a referral for any integrated/CoCM service and/or initiating, intensifying, switching and/or combining antidepressant medications) at an index visit. We used multilevel logistic regression analysis (level 1 is the patient with an eligible visit, level 2 the PCP) to test our hypotheses. Odds ratios (ORs) and 95% CIs were based on these analyses.

Results

There were 605 eligible patients with 757 visits in the post-implementation period. The mean age was 48 (SD=17); 486 (80%) were female, 15% Black, 51% Hispanic and 32% Spanish speaking; 41% were on an antidepressant. Patient treatment optimization in the intervention vs. EUC arms was 39.1% vs. 44.9% (OR=0.78; 95% CI 0.50, 1.22, p =0.27). Pre- vs. post-implementation, patient treatment optimization increased from 30.0% to 39.1% (p=0.10) and 30.4% to 44.9% (p=0.001) in the intervention and EUC arms (p=0.22 for differential change). There were similar trends in PCP optimization behaviors. There was low fidelity to the DepCare tool.

Conclusions and relevance

Our study demonstrates little added benefit of a multi-level over a system-level strategy as it relates to treatment optimization, with only system-level strategies demonstrating pre-post improvements. Negative unintended impacts of multi-level, particularly clinician targeted, strategies should be explored.

Key Points

Question

Is a theory-informed system-level strategy better than a multi-level strategy for improving population wide depression treatment optimization in integrated primary care settings?

Findings

In this comparative effectiveness randomized control trial of 2 implementation strategies for improving depression treatment optimization in integrated care settings, a multi-level strategy was no better than a system-level strategy for improving patient and clinician treatment optimization behaviors. Only the system-level strategy exhibited significant pre-post improvement in patient optimization.

Meaning

This is the first study to combine implementation and behavioral science to target treatment optimization in integrated care settings. We suggest that multi-level strategies that include clinician behavioral support may not be helpful and even harmful for improving population wide outcomes.

Article activity feed